Headache News and Research

Latest Headache News and Research

Study reports increased numbers of SARS-CoV-2-reactive T cells in individuals who were HCoV-reactive

T cell responses were measured to three SARS-CoV-2-associated antigens, as well as the endemic coronaviruses HCoV-OC43 and HCoV-NL63.

25 Apr 2022

World Malaria Day 2022: How the knockdown of P. falciparum RAP01 and RAP21 proteins could lead to novel antimalarial therapeutics

As part of World Malaria Day 2022, we interview Karine Le Roch PH.D., about her latest research into how novel antimalarial therapeutic strategies could be on the horizon, after identifying two proteins that are critical to the survival of the malaria parasite, Plasmodium falciparum.

25 Apr 2022

4% patients with COVID-19 shed fecal viral RNA 10 months after diagnosis

Researchers explore how the presence of SARS-CoV-2 RNA in feces can be associated with the presentation of GI symptoms.

24 Apr 2022

Impact of binding antibody titers and RBD-ACE2 interaction inhibition titers on Omicron breakthrough infections

Researchers investigated the effect of binding antibodies on SARS-CoV-2 Omicron breakthrough infections.

21 Apr 2022

Waning antibody responses in SARS-CoV-2-infected children and adults over time

In a new study, researchers evaluated the duration of antibodies against SARS-CoV-2.

20 Apr 2022

Better understanding of hydrocephalus could lead to improved treatments

Hydrocephalus, or "water on the brain," occurs when the cerebral ventricles-; four interconnected cavities of the brain that are filled with cerebrospinal fluid-; become enlarged, but its cause is unknown in many cases.

18 Apr 2022

Around the world, 1.25 billion people have headaches today

An update on the global prevalence of headaches and assesses the impact of methodological elements on prevalence estimates.

18 Apr 2022

New study paves the way for first drug treatment for sleep apnea

A new University of Gothenburg study has paved the way for the first drug treatment for sleep apnea. Compared to before receiving the treatment, breathing pauses decreased with on average more than 20 per hour for patients given the drug.

15 Apr 2022

Dietary influences on long COVID in children

A new study discusses possible mechanisms of long COVID in children and how they might relate to their dietary intake of important vitamins and elements.

13 Apr 2022

When symptoms linger for weeks, is it long covid?

Many Americans are discovering that recovering from covid-19 may take weeks or even months longer than expected, leaving them with lingering symptoms like intense fatigue or a racing pulse. But does that mean they have what's known as long covid?

13 Apr 2022

Review: 52% of the global population affected by headache disorder every year

A new review of the evidence suggests 52% of the global population are affected by a headache disorder every year, with 14% reporting migraines. The review is published in The Journal of Headache and Pain.

12 Apr 2022

Safety, reactogenicity, and immunogenicity of the BNT and half-m1273 mRNA COVID-19 vaccines given as a fourth dose booster

Researchers evaluated the immunogenicity of Pfizer’s BNT162b2 and Moderna’s mRNA-1273 vaccines offered as the fourth dose against SARS-CoV-2.

12 Apr 2022

Differences in symptoms and risk of hospitalization following infection with Omicron or Delta SARS-CoV-2 variants among vaccinated people

A recent study assessed the prevalence of SARS-CoV-2 symptoms and the risk of hospitalization in vaccinated individuals infected with SARS-CoV-2 Omicron and Delta variants.

12 Apr 2022

Chromatin accessibility as an early marker of severe COVID-19

A new study explores the possible use of chromatin remodeling in predicting a severe clinical trajectory for COVID-19.

11 Apr 2022

Scientists are searching for the ‘perfect protein’ to develop mRNA-based malaria vaccine

After the success of mRNA vaccines against COVID-19, scientists are cautiously optimistic that the same technology can be used to tackle other widespread diseases such as malaria.

7 Apr 2022

People with some types of epilepsy may have a lower quality of life, study suggests

A new study suggests that people with epilepsy associated with head injuries, especially the type not well controlled by medication, are more likely to have other health conditions like depression, post-traumatic stress disorder (PTSD), back pain and headache that may result in them reporting a lower quality of life.

6 Apr 2022

Headache News and Research

Latest Headache News and Research

Study reports increased numbers of SARS-CoV-2-reactive T cells in individuals who were HCoV-reactive

World Malaria Day 2022: How the knockdown of P. falciparum RAP01 and RAP21 proteins could lead to novel antimalarial therapeutics

4% patients with COVID-19 shed fecal viral RNA 10 months after diagnosis

Impact of binding antibody titers and RBD-ACE2 interaction inhibition titers on Omicron breakthrough infections

Waning antibody responses in SARS-CoV-2-infected children and adults over time

Better understanding of hydrocephalus could lead to improved treatments

Around the world, 1.25 billion people have headaches today

New study paves the way for first drug treatment for sleep apnea

Dietary influences on long COVID in children

When symptoms linger for weeks, is it long covid?

Review: 52% of the global population affected by headache disorder every year

Safety, reactogenicity, and immunogenicity of the BNT and half-m1273 mRNA COVID-19 vaccines given as a fourth dose booster

Differences in symptoms and risk of hospitalization following infection with Omicron or Delta SARS-CoV-2 variants among vaccinated people

Chromatin accessibility as an early marker of severe COVID-19

Scientists are searching for the ‘perfect protein’ to develop mRNA-based malaria vaccine

People with some types of epilepsy may have a lower quality of life, study suggests

Study explores incidence of cardiac impairment a year after SARS-CoV-2 infection

Insights into the pathophysiology of NeuroCOVID

Researchers explore the link between immunoglobulins and blood profile in severe SARS-CoV-2 patients

Researchers identify novel SARS-CoV-2 Delta-Omicron recombinant strain in Europe

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Headache News and Research

Latest Headache News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in